NKE
NIKE, Inc.
NKE has lower modeled downside risk, despite its lower overall score.
SHAK
Shake Shack Inc.
SHAK has the edge over NKE overall, supported by stronger modeled upside and stronger fundamentals.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
SHAK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
SHAK's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over SHAK in the historical PE scenario, which offers more potential upside but is not a forecast.
SHAK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 71x | $72.68 | — |
| Cheap | 75x | $77.60 | +6.8% |
| Fair | 153x | $158 | +117% |
| Expensive | 505x | $520 | +616% |
Historical ranges are pointers, not guarantees.
SHAK's PE is in its cheap range at 71x.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
SHAK Forward outlook
There aren't enough analyst estimates for SHAK to show an outlook.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
SHAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.03 | 0% |
| Q2 2026 | $0.94 | +100% |
| Q1 2026 | $0.98 | +238% |
| Q4 2025 | $1.09 | +354% |
| Q3 2025 | $1.03 | +442% |
| Q2 2025 | $0.47 | -27% |
| Q1 2025 | $0.29 | -49% |
| Q4 2024 | $0.24 | -50% |
SHAK has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over SHAK on profitability, with a higher operating margin.
SHAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $423.3M | +15% |
| Q2 2026 | $417.6M | +17% |
| Q1 2026 | $366.7M | +14% |
| Q4 2025 | $400.5M | +22% |
| Q3 2025 | $367.4M | +16% |
| Q2 2025 | $356.5M | +13% |
| Q1 2025 | $320.9M | +10% |
| Q4 2024 | $328.7M | +15% |
SHAK has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.1% | 0 points |
| Q2 2026 | 5% | -1.3 points |
| Q1 2026 | -0.7% | -1.6 points |
| Q4 2025 | 4.7% | +1.6 points |
| Q3 2025 | 5% | +11 points |
| Q2 2025 | 6.3% | +2.9 points |
| Q1 2025 | 0.9% | +0.9 points |
| Q4 2024 | 3.1% | +3.6 points |
SHAK's operating margin was 5.1% last quarter, about level with the same quarter a year ago, near the top of its range since 2019.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE has the edge over SHAK on cash generation, producing positive trailing cash flow while its opponent burns cash.
SHAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.1M | -45% |
| Q2 2026 | -$736K | -103% |
| Q1 2026 | -$38.7M | -2170% |
| Q4 2025 | $4M | -62% |
| Q3 2025 | $23.7M | +237% |
| Q2 2025 | $26.9M | +31% |
| Q1 2025 | $1.9M | +$4.3M |
| Q4 2024 | $10.4M | +23% |
SHAK's free cash flow was −$22M over the past year, against $63M the year before.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
SHAK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +44K shares |
| 1 year | +0.1% | +36K shares |
| 3 years | -4.7% | -2.1M shares |
| 5 years | +7.1% | +2.8M shares |
| Available history | +30% | +9.7M shares |
SHAK has the edge over NKE on shareholder dilution, with a more favorable share count trend.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
SHAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.6x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
SHAK has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
SHAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 75.5 | Neutral |
SHAK's weekly RSI is 53 (neutral) and its Stochastic is 76 (neutral).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over SHAK on valuation relative to its sector.
SHAK PE vs Consumer Cyclical Sector
| Metric | SHAK | Sector median | Relative |
|---|---|---|---|
| PE | 71x | 18x | 292% above |
| PE % | 11 | 47 | 36 pts below |
SHAK is trading at 71x earnings, a 292% premium to the Consumer Cyclical sector's median of 18x.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
SHAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.7 | 9% above |
| 20 week MA | $65.3 | 11% above |
| 50 week MA | $75.9 | 4.3% below |
| 100 week MA | $92.0 | 21% below |
| 200 week MA | $86.9 | 16% below |
SHAK has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
SHAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.5 | $87.8 | +45% |
| 2021 | $87.8 | $74.5 | -15% |
| 2022 | $74.5 | $44.9 | -40% |
| 2023 | $44.9 | $74.1 | +65% |
| 2024 | $74.1 | $132.6 | +79% |
| 2025 | $132.6 | $83.8 | -37% |
| 2026 YTD | $83.8 | $72.7 | -13% |
SHAK has the edge over NKE on returns for 2026, with the stronger performance.